Tag
#ahcj19
-
FTC charges in Shkreli case shed light on need for new generic drug development
The Federal Trade Commission and State of New York late last month filed a lawsuit against Martin Shkreli, charging that…
-
Panel hears how drug price reform efforts could work – or not
One question Julie Appleby posed to a panel she moderated on the high cost of prescription drugs was simple enough:…
-
•
A reporter went public when denied an interview. Here’s what happened next …
David Abel had had enough. The Boston Globe’s environmental writer was used to being denied interviews with state scientists and…
-
Health Journalism 2019 sets attendance record
Drawn by an influential lineup of speakers and panels – plus an intriguing offering of field trips – more than…
-
Panel learns why there’s no easy fix for high drug prices
One of the best sessions at Health Journalism 2019 in Baltimore was the panel discussion about drug prices on May…
-
Panelists explain how to begin mastering medical studies
At some point almost all health care journalists will need to cover a medical study or two. When that happens,…
-
Scientists look for new antimicrobials and urge government incentives
Researchers are looking to old drugs, plants and viruses in a race to find new ways to kill disease-causing microbes…
-
•
Diversifying your sources can improve your reporting
It’s an easy trap to fall into: call the hospital public relations department and ask to speak with an authority…
-
•
Panelists break down the realities of precision medicine and immunotherapy
Are precision medicine and immunotherapy overhyped as cancer treatments, or do they hold such tremendous promise that we are only…
-
Opioid epidemic, rural health spurring wider adoption of telehealth, panel says
In just the past few years, telehealth has gained some momentum, in part spurred by the opioid epidemic and an…